Related by context. All words. (Click for frequent words.) 62 Multiple logistic regression 61 beta carotene supplementation 60 Multivariate logistic regression 60 mammographically 60 Screening Trial DMIST 59 telomere lengths 59 Cochrane reviewers 59 multiple logistic regression 58 #F FDG PET 58 RE LY trial 58 probiotic supplementation 58 serum GGT 58 retrospective cohort 58 randomized controlled trials RCTs 58 BEXXAR Therapeutic Regimen 58 Subgroup analysis 58 serum lipid levels 58 Multivariable logistic regression 57 postmenopausal hormones 57 eculizumab therapy 57 logistic regression analyzes 57 CIMZIA ™ 57 ConclusionThis 57 vitro experiments 57 oncologic outcomes 57 bovine thrombin 57 Univariate analysis 56 Ismail Beigi 56 metaanalysis 56 pharmacokinetic characteristics 56 Multivariate analysis 56 NHANES III 56 metabolomic profiles 56 Afatinib 56 colorectal neoplasia 56 bezafibrate 56 macrolide antibiotic 56 Digital Mammographic Imaging 56 Rasenick 56 Oreopoulos 55 dietary questionnaires 55 TCF#L# gene 55 selenium supplementation 55 dietary glycemic index 55 Simin Nikbin Meydani 55 multivariate analyzes 55 VADT 55 Meta analyzes 55 DMIST 55 NHANES #-# 55 Quadramet 55 LANTUS ® 55 inactivated influenza vaccines 55 GnRH agonists 55 meta regression 55 antioxidant supplementation 55 Wisconsin Sleep Cohort 55 genetic polymorphisms 55 PLCO trial 55 FDG PET scans 55 Subgroup analyzes 55 Epidemiologic studies 55 core needle biopsies 55 EEG recordings 55 Regression analyzes 54 magnetic resonance spectroscopy MRS 54 ALB # 54 inecalcitol 54 meta analysis pooling 54 Remifemin R 54 psychiatric comorbidities 54 Multivariate analyzes 54 riociguat 54 Macaca mulatta 54 chemoprevention trials 54 Logistic regression 54 journal Gynecologic Oncology 54 retrospective observational study 54 pharmacokinetic studies 54 Observational studies 54 antiandrogens 54 galiximab 54 pharmacokinetic pharmacodynamic 54 CP CPPS 54 microarray gene expression 54 NMDA receptor antagonists 54 pharmacodynamic properties 54 genotypic resistance 54 testosterone supplementation 54 antidepressants SSRIs 54 lipid lowering agents 54 Health Initiative Observational 54 equol producers 54 Histopathological 54 Lipoic acid 54 clomipramine 54 Rigorous scientific 54 prospective observational studies 54 SE5 OH containing 54 transient elastography 54 ziconotide 53 adenoma recurrence 53 Randomized trials 53 CARE HF 53 Cochrane Systematic Review 53 zoledronate 53 journal Rheumatology 53 Vlachopoulos 53 creatine supplementation 53 nicotinic acid 53 bazedoxifene conjugated estrogens 53 ginkgo biloba extract 53 narcolepsy cataplexy 53 prospective longitudinal 53 statistically significant correlations 53 Michael F. Leitzmann 53 autopsied brains 53 selective modulator 53 urothelial cancer 53 NOD mouse 53 transgenic rats 53 Paul Thornalley 53 mu opioid 53 longitudinal cohort study 53 Auwerx 53 NATRECOR ® 53 Edward Giovannucci 53 infantile colic 53 RSD# oral 53 journal BJOG 53 univariate analyzes 53 GRNCM1 53 salmeterol fluticasone 53 ACOSOG Z# 53 APOE genotype 53 pentoxifylline 53 CCCEH 53 CRF antagonists 53 susceptibility loci 53 cytotoxic agents 53 Hepatotoxicity 53 SAMe 53 developmental neurotoxicity 53 NB S# strontium malonate 53 atypical neuroleptics 53 Singh Manoux 53 observational cohort study 53 Netherlands Cohort Study 53 sulphonylureas 53 antiemetics 53 Prostate Lung Colorectal 53 dexmedetomidine 53 exploratory endpoints 53 Francesca Bravi 53 Aspergillus nidulans 53 somatic mutations 52 Previous observational studies 52 BARI 2D 52 methodological limitations 52 intracranial stenosis 52 symptomatic VTE 52 PLCO 52 liver biopsies 52 radiographic outcomes 52 Sina Bavari 52 obese postmenopausal 52 recurrent miscarriage 52 Lancet Oncology journal 52 CALGB 52 LHRH agonists 52 β blockers 52 inhaled budesonide 52 comorbid illnesses 52 gene expression profiles 52 Stacy Tessler Lindau 52 Wactawski Wende 52 Sudha Seshadri MD 52 mitochondrial proteins 52 opiods 52 Dr. Chenchen Wang 52 liver transplant recipients 52 ICSI cycles 52 Tony Wyss Coray 52 Dr. Pasinetti 52 Teriparatide 52 Dr. Loeken 52 Leon Flicker 52 mechanistic studies 52 Pharmacokinetic studies 52 pharmacodynamic parameters 52 stem cell transplantations 52 conventional angiography 52 Neuroepidemiology 52 olaparib 52 Oxymorphone ER 52 Symptom severity 52 Carotid Revascularization Endarterectomy vs. 52 pyridostigmine 52 antiphospholipid antibodies 52 Recurrence Scores 52 CARDIA study 52 genomewide association studies 52 Boffetta 52 Yikyung Park 52 degree Khaled Kapoun 52 chlamydial infection 52 convergent validity 52 beta1 integrin 52 ExTRACT TIMI 52 Mantzoros 52 Buijsse 52 Intravenous immunoglobulin 52 journal Maturitas 52 CYP#D# inhibitor 52 genetic variants associated 52 myopathy rhabdomyolysis 52 limiting generalizability 52 biochemical abnormalities 52 multicenter randomized controlled 52 subgroup analyzes 52 thromboembolic complications 52 demonstrated antitumor activity 52 clevidipine 52 infliximab Remicade 52 FXIII 52 Dr. ATW Simeons 52 neuroimaging studies 52 LT NS# 52 PRIMO CABG 52 JoAnn Manson 52 anthropometric measurements 52 Jurgen Rehm 52 anti androgen 52 engineered urethras 52 sibutramine Meridia 52 microtubule targeting 52 Undesirable alterations 52 impaired insulin secretion 52 paroxetine sertraline 52 pT2 52 cardioprotective effects 51 Randomised controlled trials 51 solifenacin 51 antiresorptive 51 extracapsular extension 51 prelicensure 51 hormone therapy HT 51 Phylogenetic analyzes 51 osteoid 51 drinking beetroot juice 51 atypical antipsychotic medications 51 perioperatively 51 pharmacokinetic PK study 51 Dr. Dadachova 51 NT proBNP assay 51 Nesiritide 51 journal Neuropsychopharmacology 51 metabolomic profiling 51 pulp metallic 51 Schunkert 51 ergot alkaloids 51 colorectal carcinogenesis 51 Tsimikas 51 Nephrology Dialysis Transplantation 51 androgen suppression 51 oral diclofenac 51 genetic loci 51 Prostate Cancer Prevention 51 National Trauma Databank 51 genomewide association study 51 venlafaxine Effexor 51 Dr. Fombonne 51 rBChE 51 INTERHEART study 51 MERLIN TIMI 51 oral antidiabetic medication 51 Aging USDA HNRCA 51 fructose intolerance 51 antiepileptics 51 logistic regression models 51 haplotype map 51 gabapentin Neurontin 51 GBA mutations 51 flavonoid intake 51 neurodevelopmental outcomes 51 Shlipak 51 journal Ophthalmology 51 Logistic regression analysis 51 Clinical Gastroenterology 51 thiazide 51 Leitzmann 51 journal Neuropsychology 51 anticoagulant warfarin 51 multicenter trials 51 Sensitivity analyzes 51 multivariate regression 51 adjuvant therapies 51 nitroprusside 51 ZD# [001] 51 thyroxine T4 51 ibandronate 51 sonographically 51 fluoxetine Prozac 51 AGILECT R 51 HU# [002] 51 nonsevere 51 Dr. Gambotto 51 prospective nonrandomized 51 LJ# [002] 51 Screening Trial 51 lignan intake 51 topical NSAIDs 51 airway responsiveness 51 Schaffir 51 attain statistical significance 51 phylogenetic analyzes 51 semiquantitative 51 non fasting triglycerides 51 Valdoxan 51 TAXUS VI 51 journal Transfusion 51 Cardiotoxicity 51 STEP BD 51 CHAMPION PCI 51 nicardipine 51 Atomoxetine 51 denileukin diftitox 51 S. maltophilia 51 See CLINICAL PHARMACOLOGY 51 Kozyrskyj 51 Sacktor 51 bronchodilatory 51 Klotho gene 50 estrogen estradiol 50 chimeric protein 50 intermittent dosing 50 NPH insulin 50 retrospectively analyzed 50 oral hypoglycemic 50 prucalopride 50 serum cortisol 50 CRLX# 50 multicentre prospective 50 Dr. Sudha Seshadri 50 astemizole 50 CARDIA 50 extrapyramidal symptoms 50 embryonic stem cells ESCs 50 somatostatin analogues 50 biphasic insulin 50 bile acid metabolism 50 pharmacokinetic interactions 50 immunologic responses 50 ICD therapy 50 tamoxifen raloxifene 50 MCF7 cells 50 Proellex TM 50 retrospective cohort study 50 metabonomics 50 Chodick 50 Natural S equol 50 vidofludimus 50 familial clustering 50 anti androgens 50 suboptimal adherence 50 placebo controlled studies 50 precaution Wiehle 50 budesonide foam 50 PARTNER Trial 50 haematologic 50 ALLHAT 50 Framingham Offspring 50 mitochondrial DNA mtDNA 50 unmeasured confounders 50 later Ettore Campogalliani 50 RRMS patients 50 PLoS ONE journal 50 histopathologic diagnosis 50 journal BJU International 50 Lactobacillus GG 50 Reynolds Risk Score 50 leukotriene receptor antagonists 50 SNALP formulations 50 psychiatric outpatients 50 MAPCs 50 adrenal suppression 50 PROactive study 50 Demark Wahnefried 50 decompensated liver disease 50 MBCT 50 neuroleptic 50 paroxetine Seroxat 50 prospective multicentre 50 tiotropium Spiriva 50 predictive validity 50 Susanna Larsson 50 number NCT# ClinicalTrials.gov 50 Stella Adler Lee Strasberg 50 Barbara Sahakian 50 K ras mutation 50 conventional antipsychotics 50 fruitfly Drosophila 50 abacavir Ziagen 50 fulvestrant 50 Hypoglycaemia 50 pathogenetic mechanisms 50 Limperopoulos 50 Human Reproduction journal 50 fMRI scans 50 nulliparous women 50 mammographic density 50 plasminogen activators 50 HF ACTION 50 Mechanistic studies 50 Intervention Trial GAIT 50 Timothy Rebbeck 50 Processed meat 50 miRNA expression 50 intravenous immunoglobulin IVIg 50 journal CHEST 50 Framingham Offspring Study 50 subclinical hypothyroidism 50 perinatal outcomes 50 moderately heritable 50 FDDNP 50 journal Chemosphere 50 dietary antioxidants 50 Chavarro 50 intermittent hypoxia 50 Dr. Edward Giovannucci 50 phase IIIb 50 Ordovas 50 RCTs 50 journal Appetite 50 medical journal Thorax 50 Carvedilol 50 anagrelide 50 pharmacokinetic parameters 50 genomewide 50 clinicopathological 50 NeuroImage 50 gestational diabetes mellitus GDM 50 serum retinol 50 Johan Auwerx 50 BRCA testing 50 LibiGel Phase III 50 secretin 50 Swedish Mammography Cohort 50 journal Urology 50 paclitaxel eluting stents 50 comorbid anxiety 50 pathophysiological mechanisms 50 epidemiologic studies 50 acamprosate 50 CYP#A# inhibitors 49 raloxifene Evista 49 desvenlafaxine succinate 49 Okunieff 49 Munk Olsen 49 overt hypothyroidism 49 journal Behavioral Neuroscience 49 preclinical efficacy 49 agomelatine 49 methylphenidate Ritalin 49 journal Menopause 49 antiplatelet therapies 49 Dietary intake 49 haloperidol Haldol 49 PREVENT IV 49 bone density measurements 49 #mg dose [001] 49 pharmacodynamic markers 49 metabolic syndrome MetS 49 Hydroxyurea 49 IgG isotype 49 journal Carcinogenesis 49 EFP weapon 49 HORIZONS AMI trial 49 mice genetically altered 49 abdominal adiposity 49 euthymic 49 HIV seroconversion 49 leptin deficient mice 49 Lancet Neurology journal 49 Multicenter AIDS 49 APTIVUS r 49 tricyclic anti depressants 49 Christiane Reitz 49 vitro studies 49 Eligen R B# 49 xanthine oxidase inhibitor 49 journal Phytotherapy Research 49 elevated creatinine 49 prospective observational cohort 49 GLIADEL R Wafer 49 RIO Lipids 49 immunological responses 49 mechanistic insights 49 proteomes 49 Nalini Ranjit 49 inbred strains 49 plastid 49 Eva Lonn 49 lactulose 49 PROTEGE trial 49 receptor blocker 49 oxcarbazepine 49 Navelbine ® 49 calcium antagonists 49 invasive carcinoma 49 STK# gene 49 longitudinal cohort 49 noscapine 49 hormones ghrelin 49 mixed hyperlipidemia 49 thorough QT 49 perfusion CT 49 Arrigo Pola 49 microsatellite markers 49 randomized controlled clinical trials 49 antipsychotic prescribing 49 thiamine vitamin B1 49 Dr. Vitetta 49 chemoradiotherapy 49 Temsirolimus 49 laparoscopic bariatric surgery 49 Dickersin 49 aspirin clopidogrel 49 RESOLUTE clinical 49 masitinib 49 journal Thorax 49 antidiabetic 49 Telmisartan 49 Carbohydrate polymers 49 Overactive Bladder OAB 49 peptoids 49 clinical pharmacology studies 49 bacterial fermentation 49 cortical activation 49 Nonalcoholic Steatohepatitis 49 journal Resuscitation 49 LLLT 49 Dr. Tashkin 49 Dr. Yolton 49 Karolinska Institute Stockholm 49 Thalomid ® 49 visceral metastases 49 preclinical pharmacokinetic 49 Shanna Swan 49 tiotropium bromide 49 insulin detemir 49 transcriptomics 49 postmenopausal hormone therapy 49 Valproate 49 FOSRENOL R 49 CYP #A# 49 dietary acrylamide 49 mycophenolate mofetil 49 hMSCs 49 Melov 49 etanercept Enbrel 49 typical antipsychotics 49 Clinical Antipsychotic Trials 49 ABSORB trial 49 dihydroergotamine 49 Pemetrexed 49 ventricular myocardium 49 Arixtra ® 49 interferon alfa 2b 49 bacterial prostatitis 49 Dialysis Outcomes 49 RSD# 49 sitaxsentan 49 inhaled bronchodilators 49 extrapulmonary disease 49 antiangiogenic agents 49 thalidomide Thalomid 49 Trey Ideker 49 HCV SPRINT 49 cancer chemoprevention 49 highly pathogenic viruses 49 immunomodulatory agents 49 internalizing behaviors 49 pharmacological interventions 49 biologic plausibility 49 neuropsychiatric symptoms 49 HER2 positive breast 49 NLSY 49 Early Childhood Longitudinal Study 49 genetic determinants 49 atorvastatin #mg 49 paroxetine Paxil 49 gallium nitrate 49 selegiline 49 NHANES 48 Theoretical calculations 48 chromium supplementation 48 tricyclic antidepressant 48 functional neuroimaging 48 coadministration 48 Normative Aging Study 48 genetically reprogramming 48 UKPDS 48 observational cohort 48 Kristine Yaffe MD 48 HuMax EGFr 48 double blinded randomized 48 trials RCTs 48 triptan therapy 48 Suicidality 48 Professor Najman 48 generalisability 48 Lamotrigine 48 journal Gut 48 PRESEPT study 48 Complications Trial 48 tumor necrosis 48 topiramate Topamax 48 randomized multicenter trial 48 virologic breakthrough 48 Paxil paroxetine 48 MDR1 48 Stenting Trial CREST 48 tau protein tangles 48 NIASPAN 48 Effexor venlafaxine 48 methodologic 48 Baltimore Longitudinal Study 48 biologic DMARDs 48 HMG CoA reductase inhibitor 48 CT perfusion 48 Dr. Sosne 48 longitudinal observational study 48 Deutsches Arzteblatt International 48 Emily Oken 48 antidiabetic agents 48 mild gestational diabetes 48 eosinophilic asthma 48 chemoradiation therapy 48 AVERROES 48 folate supplementation 48 lipid lowering therapy 48 magnesium supplementation 48 journal Neuropsychologia 48 meta analytic 48 Spiriva HandiHaler 48 DeKosky 48 radiographic examinations 48 Dr. Masashi Yanagisawa 48 BMC Psychiatry 48 placebo controlled trials 48 serum lipids 48 PM#.# exposure 48 Hyon Choi 48 tiagabine 48 NITD# 48 detect XMRV 48 plant Arabidopsis 48 methylation patterns 48 Dengue Hemorrhagic Virus 48 utero exposure 48 glitazones 48 journal Anesthesiology 48 cordycepin 48 Soffritti 48 ROCHESTER Minn. Mayo Clinic 48 WTCCC 48 Dr. Chodick 48 buproprion 48 spontaneous regression 48 EMPHASIS HF trial 48 Bicalutamide 48 NSDUH 48 pimecrolimus 48 tastants 48 rALLy trial 48 placebo controlled dose escalation 48 poststroke depression 48 Educational Longitudinal Study 48 M. anisopliae 48 ziprasidone 48 Lambris 48 PET CT scans 48 bronchopulmonary dysplasia BPD 48 multicenter placebo controlled 48 Neoadjuvant chemotherapy 48 journal Animal Behaviour 48 NO# [002] 48 Boston DbTechNo Results 48 genomically 48 pharmacodynamic endpoints 48 Victor Velculescu 48 ziprasidone Geodon 48 P. boisei 48 histologically 48 Kay Tee Khaw 48 multicenter Phase II 48 piroxicam 48 NHAMCS 48 AIR2 Trial 48 desmopressin 48 randomized crossover 48 dextromethorphan DM 48 DHA supplementation 48 SEER database 48 Nutrition Examination Surveys 48 observational studies 48 ARB telmisartan 48 Dr. Hakon Hakonarson 48 cinacalcet 48 journal Pharmacotherapy 48 tegaserod 48 overactive bladder symptoms 48 carotid atherosclerosis 48 Molecular Psychiatry 48 Bibbins Domingo 48 Evaluation WISE 48 Phase IIIb study 48 PPAR gamma agonists 48 GLP 1R 48 globular proteins 48 preoperative MRI 48 Vimpat R 48 resistin 48 biologic DMARD 48 antiplatelet drugs 48 alpha hydroxyprogesterone caproate 48 Prelox 48 nutrient supplementation 48 WHEL 48 periprocedural MI 48 dose dependently 48 journal Biomacromolecules 48 Clinical Infectious Disease 48 HNRCA 48 labetalol 48 journal Chemical Senses 48 NUCYNTA ™ 48 amifostine 48 GERD migraine headaches 48 norethindrone acetate 48 Chicago Multidisciplinary Symposium 48 pathophysiologic mechanism 48 WHIMS 48 pharmacological therapies 48 Tomas Prolla 48 risedronate Actonel 48 BJU International 48 journal Ambulatory Pediatrics 48 Parnate 47 journal Cerebral Cortex 47 Thiazolidinediones 47 Nutrition Examination Surveys NHANES 47 microbiomes 47 nomograms 47 Accumulating evidence 47 bought Glaxo Serevent 47 Selective Serotonin Reuptake Inhibitors 47 edifoligide 47 genetically altered mice 47 serotonin reuptake inhibitor 47 EMBL scientists 47 detemir 47 dexrazoxane 47 epidemiological studies 47 Buhimschi 47 systemic hypotension 47 Zyban bupropion 47 statistically significant correlation 47 dosing frequency 47 bromocriptine 47 prodromal symptoms 47 HIF PHIs 47 Cassini magnetometer instrument 47 Starlix 47 meta analysis 47 nonsteroidal 47 neuroprotective effects 47 pulmonary toxicity 47 Nutritional Examination Survey 47 Epidemiological studies 47 gene expression patterns 47 anticholinergic drugs 47 multicenter clinical trials 47 monoamine oxidase inhibitors 47 Plenaxis TM 47 candesartan cilexetil 47 DACH platinum 47 nematode Caenorhabditis elegans 47 journal PNAS 47 antiplatelet medications 47 ACEIs 47 GliSODin 47 Cholesterol Levels SPARCL 47 PharmaVOICE editors 47 CAPHOSOL 47 journal Diabetologia 47 Erectile function 47 glatiramer 47 intranasal corticosteroid 47 bivariate analyzes 47 Etminan 47 betamethasone 47 SNRI 47 remifentanil 47 Richard Suzman Ph.D. 47 Dr. Gurbel 47 IQWiG 47 viral kinetic 47 Glucosamine chondroitin Arthritis 47 Bronchial Thermoplasty 47 iPrEx study 47 Keppra XR 47 journal Epidemiology 47 antirheumatic 47 Femara letrozole 47 milrinone 47 Hertz Picciotto 47 journal Biological Psychiatry 47 Fracture Risk 47 Previous epidemiological studies 47 mg metformin 47 syncope fainting 47 study1 47 CETP inhibition 47 psychotherapies 47 underdiagnosis 47 antioxidant enzyme 47 Redei 47 Intervention Effectiveness 47 donepezil rivastigmine 47 anticholinergic agents 47 substudy 47 Vaprisol 47 Health HSPH 47 prenatal exposures 47 genetically altered mouse 47 olanzapine LAI 47 conventional DMARDs 47 N acetylcysteine 47 ALISTA 47 p# MAP kinase inhibitor 47 G CSFs 47 Gynecologic Oncology Group 47 premenstrual syndrome PMS 47 MMRC clinical trials 47 Hycamtin ® 47 Orthostatic hypotension 47 Neural stem cells 47 DMARDS 47 REVIVE Diabetes 47 antiarrhythmic drugs 47 EXJADE 47 magnesium intake 47 antiarrhythmic 47 lenalidomide dexamethasone 47 Bulimia Nervosa 47 AMOR IPAT 47 DMSc 47 acamprosate calcium 47 subanalysis 47 agonist antagonist 47 green tea catechins 47 journal Molecular Psychiatry 47 CHAMACOS 47 randomized controlled trials 47 Manfred Kayser 47 incretin hormones 47 Alicja Wolk 47 5 HT1A 47 thyroid deficiency 47 aneuploid cells 47 Dr. Victor Velculescu 47 Avanafil 47 neratinib 47 journal Preventive Medicine 47 toxicological studies 47 reanalysed 47 National Epidemiologic Survey 47 journal Arteriosclerosis Thrombosis 47 Phytotherapy Research 47 Insulin Resistance Atherosclerosis 47 thyroxine 47 Tesmilifene 47 linear regression analyzes 47 intravenous dosing 47 proteomic technologies 47 Cochrane Database 47 ALVESCO HFA 47 poorly immunogenic 47 Halpern Felsher 47 MSLT 47 PBDE exposure 47 Betaferon R 47 inverse association 47 Sherine Gabriel 47 Dr. Montori 47 elective percutaneous coronary 47 tricyclic antidepressants 47 bioassays 47 colesevelam HCl 47 Millennium Cohort Study 47 journal Addictive Behaviors 47 X chromosome inactivation 47 disulfiram 47 Panksepp 47 actigraphy 47 hyperglycaemia 47 Subclinical 46 Clinical Endocrinology & 46 placebo controlled clinical 46 tranylcypromine 46 sertraline Zoloft 46 postmarketing surveillance 46 Mathematical modeling 46 SWOG 46 Sackner Bernstein 46 Neurology Neurosurgery 46 pivotal bioequivalence 46 journal Psychopharmacology 46 Circulation Heart Failure 46 Bart De Strooper 46 Rofecoxib 46 topical calcineurin inhibitors 46 Topiramate 46 Hrushesky 46 Atherosclerosis Risk 46 adrenal function 46 Leukemias 46 Andrea Baccarelli 46 Dr. Spiera 46 fibromyalgia syndrome 46 adeno associated viruses 46 Fulvestrant 46 chiral compounds 46 B vitamin supplementation 46 Danazol 46 Shelley Salpeter 46 macronutrient intake 46 acitretin 46 MC4R gene 46 Randomized controlled 46 node metastases 46 torcetrapib atorvastatin 46 Interferon Beta 46 tolterodine 46 journal Anaesthesia 46 divalproex sodium 46 bacterial genomes 46 inferential statistics 46 Karolinska Institutet Stockholm Sweden 46 clomiphene citrate 46 Dietary Modification Trial 46 journal Paediatrics 46 tubular diskectomy 46 glucose intolerant 46 Randomized clinical trials 46 ADVANCE PD 46 INVEGA ® 46 Eli Lilly Cymbalta 46 nonrandomized 46 Hashibe 46 Shahin Rafii 46 cardiogenic 46 omnivorous diet 46 Sociodemographic 46 genetic susceptibilities 46 conjugated equine estrogen 46 mmol kg 46 parathyroid hormone 46 Mayo Clinic oncologist 46 selective cyclooxygenase 2 46 Abilify aripiprazole 46 Benign Prostatic Hyperplasia 46 Bacillus thuringiensis bacterium 46 Kaeberlein 46 phylogenetic analysis 46 Circulatory Physiology 46 anticholinergics 46 Lone Simonsen 46 empiric treatment 46 analgesic effects 46 journal Nature Chemical Biology 46 chemopreventive agents 46 AERAS-#/Crucell Ad# 46 OPT CHF 46 journal Lancet Neurology 46 Clinical Psychopharmacology 46 gene expression microarray 46 apomorphine 46 GYTS 46 HeFT 46 PLOS Medicine 46 asthma immunotherapeutic 46 residual confounding 46 corticosteroid therapy 46 AGILECT ® 46 Pycnogenol ® 46 Selective Serotonin Re